Uniplan Investment Counsel’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
Other funds holding BLFS
CC
FAM
Uniplan Investment Counsel's BLFS Position: Q2 2026 in Review
Uniplan Investment Counsel increased its BioLife Solutions (BLFS) stake by 3% in Q2 2026, buying an estimated $128K and bringing the position to 188,330 shares worth $5.32M. The position accounts for 0.5% of the portfolio, ranked #58.
Uniplan Investment Counsel first reported a position in BLFS in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.37M in Q4 2024. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.
- Uniplan Investment Counsel held 188,330 shares of BioLife Solutions worth $5.32M as of Q2 2026.
- Uniplan Investment Counsel bought 5,493 BioLife Solutions shares in Q2 2026, an estimated $128K.
- BioLife Solutions made up 0.5% of Uniplan Investment Counsel's portfolio in Q2 2026, its #58 holding.
- Uniplan Investment Counsel first reported a position in BioLife Solutions in Q2 2022 and has held it in 17 quarters since.
- Uniplan Investment Counsel's BioLife Solutions position peaked at $6.37M in Q4 2024.
- 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.
Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.